I just learned that my Humana plan requires "step therapy" before they'll cover Wegovy. That means I have to try AND FAIL two cheaper medications first:
- Step 1: Phentermine (3 months minimum)
- Step 2: Contrave OR Qsymia (3 months minimum)
- Step 3: Only THEN can they submit a PA for Wegovy
So I need to spend 6 months on medications that are statistically less effective before I can even TRY the one that has the best evidence? My doctor is furious. She says this is clinically inappropriate — I have a BMI of 42 and she wants to start with the most effective treatment, not waste 6 months on less effective options.
Is there any way around this? The idea of deliberately taking medications my doctor doesn't recommend just to "fail" them is absurd.
Step therapy is one of the most frustrating aspects of insurance. But there ARE ways to work around it:
1. Step Therapy Exception Request: Most insurers, including Humana, have a process for requesting a step therapy exception. Your doctor needs to submit clinical justification for why the standard step therapy sequence is inappropriate for your specific case. Valid reasons include:
- Contraindication to step therapy drugs (phentermine is contraindicated with certain cardiac conditions, uncontrolled hypertension, etc.)
- History of adverse reaction to the required drugs
- Severity of condition warrants first-line use of most effective therapy
- Clinical guidelines recommend GLP-1 as first-line for BMI > 40
2. State Step Therapy Override Laws: Many states have passed laws requiring insurers to grant exceptions to step therapy. Check if your state has one — if so, the law spells out exact criteria for exceptions.
The clinical argument against step therapy for severe obesity is strong. The Endocrine Society and the Obesity Medicine Association both recommend intensity of therapy should match severity of disease. For BMI ≥ 40, guidelines support initiating the most effective available therapy first.
Here's what I include in step therapy exception requests:
Per Endocrine Society Clinical Practice Guidelines, patients with BMI ≥ 40 and/or significant obesity-related comorbidities should be considered for intensive pharmacotherapy as initial treatment. Requiring sequential failure of less effective agents delays appropriate treatment and subjects the patient to unnecessary health risks from prolonged untreated severe obesity.
I also cite the STEP trial data showing semaglutide 2.4mg achieves ~15% body weight reduction vs. ~5% for phentermine and ~4-5% for naltrexone/bupropion. The efficacy difference is significant enough to justify first-line use.
In my experience, step therapy exceptions are granted about 60% of the time when the clinical documentation is thorough.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemThank you both. I didn't even know step therapy exceptions existed. My doctor certainly didn't mention it — she just said "we have to go through the steps."
I'm in Texas. Does anyone know if Texas has a step therapy override law?
Also — if I DID have to do the step therapy, what's the fastest way through? Can I start step 1 and 2 concurrently? And does "failure" just mean it didn't cause enough weight loss, or do I need to have side effects?
Texas passed SB 1940 in 2023 — yes, Texas has a step therapy override law. It requires insurers to grant exceptions if:
- The required drug is contraindicated
- The required drug would cause an adverse reaction
- The required drug is expected to be ineffective based on the patient's clinical history
- The patient is already stable on the requested drug
- The required drug is not in the patient's best clinical interest
The insurer must respond to the exception request within 72 hours (or 24 hours for urgent requests). If they deny it, you can appeal.
To answer your other questions: steps are sequential, not concurrent. "Failure" is defined in the policy — usually it means less than 5% body weight loss after the required trial period, OR documented intolerance/side effects that led to discontinuation. Read the specific criteria in Humana's clinical policy bulletin.